24 results
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
EX-3.2
ZVRA
Zevra Therapeutics Inc
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.2
ZVRA
Zevra Therapeutics Inc
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.3
0lihw1y re
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.1
a29r316xerfryg7pd
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
8-K
EX-3.1
u0hfk7r4 1s6sp2j4
28 Dec 20
KemPharm Announces 1-for-16 Reverse Stock Split
12:00am
8-K
EX-3.1
06ndy3
21 Dec 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-3.1
ko0jb6vz70 7i03
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-3.1
k7par0g9 63
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-3.2
gnbc 6vqp49
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-3.1
bg2n5yvkdks98uctfox
5 Oct 18
KemPharm Announces Pricing of Public Offering of Common Stock
10:03am
8-K
EX-3.1
as2bxm74
21 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.2
1k6eg9u
21 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1/A
EX-3.2
lfbtuf76se6vf23b
3 Apr 15
IPO registration (amended)
12:00am
S-1
EX-3.3
11u nwb6ng43ss
11 Mar 15
IPO registration
12:00am
S-1
EX-3.1
fyuzj3wnnegntpjhoc
11 Mar 15
IPO registration
12:00am
S-1
EX-3.5
o194caezwioh4hgs
11 Mar 15
IPO registration
12:00am